US 12,296,030 B2
Conjugates and their use as imaging agents
Philip Hogg, Malabar (AU); and Ivan Ho Shon, Strathfield (AU)
Assigned to CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY, (AU); and UNIVERSITY OF SYDNEY, (AU)
Filed by Centenary Institute of Cancer Medicine and Cell Biology, Camperdown (AU); and University of Sydney, Sydney (AU)
Filed on Aug. 18, 2023, as Appl. No. 18/452,312.
Application 18/452,312 is a continuation of application No. 17/594,325, previously published as PCT/AU2020/050359, filed on Apr. 9, 2020.
Claims priority of application No. 2019901277 (AU), filed on Apr. 12, 2019.
Prior Publication US 2024/0009330 A1, Jan. 11, 2024
Int. Cl. A61K 51/04 (2006.01); A61P 35/00 (2006.01); C07F 9/78 (2006.01)
CPC A61K 51/0497 (2013.01) [A61P 35/00 (2018.01); C07F 9/78 (2013.01)] 19 Claims
 
1. A compound according to Formula (Ia)

OG Complex Work Unit Chemistry
wherein A is —As(OH)2;
and Z is selected from the group consisting of 64Cu, {Al18F}2+, 68Ga, and 99mTc;
or a pharmaceutically acceptable salt or solvate thereof.